Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

DENVER, May 12, 2020 /PRNewswire/ -- KND Labs, a leading manufacturer of hemp-derived ingredients, has earned the accreditation of Active Pharmaceutical Ingredients (API), the company announced today.

The Active Pharmaceutical Ingredients Directory contains more than 5,000 API pharmaceutical companies and 25,000 executives working in the API industry around the world. Published annually and updated ...

Plant-based Active Pharmaceutical Ingredients (APIs) Market · GlobeNewswire Inc. Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Plant-based Active Pharmaceutical Ingredients (APIs) - Global Strategic ...

DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence ...

SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% ...

LEWES, Del., Oct. 17, 2025 /PRNewswire/ -- The Global Sterile Dry Powder Active Pharmaceutical Ingredient (API) Market Size is projected to grow at a CAGR of 8.2% from 2026 to 2032, according to a new ...

(Yicai) Jan. 27 -- China has suspended the import, sale, and use of an Alzheimer's treatment and an active pharmaceutical ...